ARR Leaderboard
Abridge ARR: $100M+ in 18 Months, From $6M.
Abridge went from roughly $6M of ARR in early 2024 to $100M+ by mid-2025 — one of the fastest enterprise ramps in healthcare software — and its valuation doubled twice within five months. Every reported ARR, funding and valuation number is collected below, each traced back to a public source.
$100M+
Reported ARR, mid-2025
18 months
$6M → $100M+ ARR
$117M
Contracted ARR, Q1 2025
$5.3B
Valuation, Series E Jun 2025
The Abridge Revenue Curve.
Reported annualized run rate in USD millions, early 2024 to mid-2025. Linear scale — the clinical documentation market does the accelerating.
$6M → $60M ARR
~10 months
Early 2024 → Dec 2024
$6M → $100M+ ARR
18 months
Early 2024 → May 2025
$2.75B → $5.3B valuation
4 months
Feb 2025 → Jun 2025
Implied MRR at $100M ARR
~$8.3M / month
Derived from ARR
Every Reported ARR Milestone.
Early 2024
$6M ARR
Founded in 2018 by cardiologist Dr. Shiv Rao; the ambient AI scribe begins converting pilots into enterprise contracts, with roughly $19M ARR reported during 2024. — Sacra / Value Add VC
February 2024
$10M ARR
$150M Series C led by Kleiner Perkins and Lightspeed values Abridge around $1B as health-system adoption accelerates. — Company / Sacra
End of 2024
$60M ARR
ARR reaches $60M by year-end 2024, with 20,000+ clinicians documenting through the platform and Epic integration widening the funnel. — Sacra
February 2025
$75M ARR
$250M Series D at a $2.75B valuation — the valuation doubles in under a year. — Company / Sacra
May 2025
$100M ARR
Crosses $100M ARR — up from ~$6M eighteen months earlier — with contracted ARR reaching $117M in Q1 2025. — Sacra / Value Add VC
June 2025
$100M ARR
$300M Series E led by Andreessen Horowitz values Abridge at $5.3B — a second valuation doubling in four months — with 150+ enterprise health systems deployed. — Company / Sacra
Abridge by the Numbers.
Latest reported ARR
$100M+
Sacra / Value Add VC, mid-2025
Contracted ARR
$117M
Q1 2025
Implied MRR
~$8.3M / month
Derived from ARR
Valuation
$5.3B
Series E, Jun 2025
Total raised
$757M+
Sacra
Health systems
150+
Company, 2025
Clinicians
20,000+
Sacra, 2024
Founded
2018, Pittsburgh
Company
CEO
Dr. Shiv Rao
Company
How Per-Clinician Contracts Reach Eight Figures.
Abridge sells enterprise contracts to health systems, priced per clinician per month for ambient clinical documentation — ambient listening during patient visits turns into structured, specialty-tuned notes and billing-ready coding suggestions. Health systems typically roll it out to hundreds or thousands of clinicians at once, which is why a single expansion can move revenue in eight-figure steps.
The distribution moat is Epic: a native partnership makes Abridge the default scribe option inside the EHR most large US health systems already run, so revenue compounds through system-wide deals rather than bottom-up adoption. Contracted ARR of $117M against $100M+ recognized ARR in Q1 2025 shows a signed backlog running ahead of deployment — the usual leading indicator in enterprise healthcare.
Revenue Mix
- Per-clinician subscriptionsEnterprise contracts billed monthly per documenting clinician.
- System-wide rolloutsHealth-system agreements spanning hundreds to thousands of seats.
- Coding intelligenceStructured-note and coding-suggestion layers expanding contract value.
FAQ
Abridge Revenue, Answered.
What Is Abridge's ARR in 2026?
How Fast Did Abridge Reach $100M ARR?
How Does Abridge Make Money?
What Is Abridge's Valuation and How Much Has It Raised?
Is Abridge's ARR Officially Disclosed?
Selling to Enterprise? Get Paid Like Abridge.
Clink handles enterprise subscription billing, seat-based invoicing and merchant-of-record tax compliance for clinical AI — so health-system rollouts never wait on payments.
Bill Health Systems→